ERNEXA THERAPEUTICS
LIVE

Serial Number

99109342

Owner

ERNEXA THERAPEUTICS INC.

Attorney

BEN NATTER

Filing Date

Mar 28, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ERNEXA THERAPEUTICS Trademark

Serial Number: 99109342

ERNEXA THERAPEUTICS is a trademark filed by ERNEXA THERAPEUTICS INC. on March 28, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ERNEXA THERAPEUTICS INC. (4 trademarks)

1035 CAMBRIDGE STREET
CAMBRIDGE, MA 02141

Entity Type: 03

Eterna Therapeutics Inc. (4 trademarks)

1035 Cambridge Street, Suite 18A
Cambridge, MA 02141

Entity Type: 03

Trademark Details

Filing Date

March 28, 2025

Registration Date

Not Registered

Published for Opposition

February 3, 2026

Goods & Services

Stem cells for medical purposes; Drug delivery systems, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the treatment of rare diseases tumors, cancer, auto-immune, and inflammatory diseases; stem cell delivery agent in the form of micro-beads for use in stem cell delivery for patients; regenerative medicinal products, namely, cell, cellular component, and stem cell processing and application medical devices for medical application being cell growth media for growing cells for use medical use

Drug delivery systems, namely, implantable subcutaneous drug delivery device in the nature of drug delivery ports; drug delivery systems primarily comprised of drug delivery catheters and medical micro-robots for delivering stem cells into a targeted area in humans; stem cell delivery apparatus for medical use, namely, implantable stem cell delivery ports, medical mic-robots for stem cell delivery; medical biohybrid, synthetic and hybrid micro-robots for use in stem cell delivery for patients; apparatus for the regeneration of stem cells for medical purposes; regenerative medicinal products, namely, cell, cellular component, and stem cell processing and application medical devices for medical application being cell regeneration apparatus; regenerative medicinal products, namely, cell, cellular component, and stem cell extraction medical devices for medical application being needles for medical purposes; medical apparatuses for implementing treatment methods using stem cells

Stem cell therapy services; Providing information in the field of stem-cell therapies and stem-cell therapies related to tumors, cancer, auto-immune and inflammatory diseases; stem call bank services; medical services relating to the removal, treatment and processing of stem cells

Research and development in the field of stem-cell therapies; Research and development in the field of stem-cell therapies for treatment of tumors, cancer, auto-immune, and inflammatory diseases; research and development in the field of stem-cell therapies, namely, synthetic induced mesenchymal stem-cell therapies (iMSC); Stem cell research services

Stem cells for research or scientific purposes; stems cells for medical research

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 3, 2026 ETOP
OPPOSITION INSTITUTED NO. 999999
Jun 2, 2026 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 12, 2026 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jan 9, 2026 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 2, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 9, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 9, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 9, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 9, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 24, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 3, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 3, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 27, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2025 NWOS
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 30, 2025 ASGN
APPLICATION FILING RECEIPT MAILED
Mar 28, 2025 MAFR
NEW APPLICATION ENTERED
Mar 28, 2025 NWAP